Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web


  Free Subscription


1 Arch Virol
1 Dig Dis Sci
3 Eur J Gastroenterol Hepatol
1 Gastroenterology
3 Hepatology
1 J Immunol
1 J Interferon Cytokine Res
2 J Med Virol
1 J Virol
4 Lancet Infect Dis
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles


  1. CORMA-GOMEZ A, Morano Amado L, Tellez F, Rivero-Juarez A, et al
    HIV infection does not impact on the risk of liver complications in HCV-infected patient with advanced fibrosis, after sustained virological response with DAA.
    AIDS. 2019 Mar 5. doi: 10.1097/QAD.0000000000002186.
    PubMed     Text format     Abstract available

  2. BERENGUER J, Gil-Martin A, Jarrin I, Montes ML, et al
    Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individuals.
    AIDS. 2019;33:685-689.
    PubMed     Text format     Abstract available

    Arch Virol

  3. PENG TT, Cai QE, Yang M, Chen SP, et al
    Epidemiological trends and virological traits of hepatitis B virus infection in pregnant women and neonates.
    Arch Virol. 2019 Mar 8. pii: 10.1007/s00705-019-04190.
    PubMed     Text format     Abstract available

    Dig Dis Sci

  4. CHEN YH, Lu SN, Wang JH, Hung CH, et al
    Pre-S/Surface and Core Promoter/Precore Mutations in Chronic Hepatitis B Patients with Severe Acute Exacerbation.
    Dig Dis Sci. 2019 Mar 5. pii: 10.1007/s10620-019-05571.
    PubMed     Text format     Abstract available

    Eur J Gastroenterol Hepatol

  5. SHEHATA HH, Elfert AA, Abdin AA, Soliman SM, et al
    Randomized controlled trial of polyethylene glycol versus lactulose for the treatment of overt hepatic encephalopathy.
    Eur J Gastroenterol Hepatol. 2018;30:1476-1481.
    PubMed     Text format     Abstract available

  6. Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy: Erratum.
    Eur J Gastroenterol Hepatol. 2019;31:549.
    PubMed     Text format    

  7. DARWEESH SK, AbdElAziz RA, Abd-ElFatah DS, AbdElazim NA, et al
    Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Eur J Gastroenterol Hepatol. 2019 Mar 4. doi: 10.1097/MEG.0000000000001385.
    PubMed     Text format     Abstract available


  8. HAMDANE N, Juhling F, Crouchet E, El Saghire H, et al
    HCV-induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.
    Gastroenterology. 2019 Mar 2. pii: S0016-5085(19)32506.
    PubMed     Text format     Abstract available


  9. KWONG AJ, Kim WR, Flemming JA
    De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30045.
    PubMed     Text format     Abstract available

  10. XIE L, Yin J, Xia R, Zhuang G, et al
    Cost-effectiveness of antiviral treatment after resection in HBV-related hepatocellular carcinoma patients with compensated cirrhosis.
    Hepatology. 2018 Apr 7. doi: 10.1002/hep.29922.
    PubMed     Text format     Abstract available

  11. REN JH, Hu JL, Cheng ST, Yu HB, et al
    SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3-9 homolog 1 and SET domain containing 1A histone methyltransferases.
    Hepatology. 2018;68:1260-1276.
    PubMed     Text format     Abstract available

    J Immunol

  12. SONG H, Tan G, Yang Y, Cui A, et al
    Hepatitis B Virus-Induced Imbalance of Inflammatory and Antiviral Signaling by Differential Phosphorylation of STAT1 in Human Monocytes.
    J Immunol. 2019 Mar 6. pii: jimmunol.1800848. doi: 10.4049/jimmunol.1800848.
    PubMed     Text format     Abstract available

    J Interferon Cytokine Res

  13. ISHIDA Y, Kakuni M, Bang BR, Sugahara G, et al
    Hepatic IFN-Induced Protein with Tetratricopeptide Repeats Regulation of HCV Infection.
    J Interferon Cytokine Res. 2019;39:133-146.
    PubMed     Text format     Abstract available

    J Med Virol

  14. POORDAD F, Bennett M, Sepe TE, Cohen E, et al
    Ombitasvir/paritaprevir/ritonavir and dasabuvir with or without sofosbuvir for patients with HCV genotype 1 infection who failed a prior course of direct-acting antiviral therapy.
    J Med Virol. 2019 Mar 6. doi: 10.1002/jmv.25448.
    PubMed     Text format     Abstract available

  15. BURA M, Michalak M, Lagiedo-Zelazowska M, Bukowska A, et al
    HEV seroprevalence can significantly change after re-assessment.
    J Med Virol. 2018;90:783-785.
    PubMed     Text format    

    J Virol

  16. SAHUC ME, Sahli R, Riviere C, Pene V, et al
    Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus Is a New Inhibitor of Hepatitis C Virus RNA Replication.
    J Virol. 2019 Mar 6. pii: JVI.02009-18. doi: 10.1128/JVI.02009.
    PubMed     Text format     Abstract available

    Lancet Infect Dis

  17. WEDEMEYER H, Yurdaydin C, Hardtke S, Caruntu FA, et al
    Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial.
    Lancet Infect Dis. 2019;19:275-286.
    PubMed     Text format     Abstract available

  18. ZHOU YH
    Maternal immunisation and neonatal infection of hepatitis A or B virus.
    Lancet Infect Dis. 2019;19:238.
    PubMed     Text format    

  19. BENGTSON AM, Sanfilippo AM, Hughes BL, Savitz DA, et al
    Maternal immunisation and neonatal infection of hepatitis A or B virus - Authors' reply.
    Lancet Infect Dis. 2019;19:238-239.
    PubMed     Text format    

  20. BURKI T
    Eliminating hepatitis C.
    Lancet Infect Dis. 2019;19:246-247.
    PubMed     Text format    

    PLoS One

  21. GANOVA-RAEVA L, Dimitrova Z, Alexiev I, Punkova L, et al
    HCV transmission in high-risk communities in Bulgaria.
    PLoS One. 2019;14:e0212350.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.